Experimenter at tissue culture hood MI-mAbs

News

Immuno 2024

MImAbs is attending Immuno 2024 from April 25th to 26th 2024 in London, UK.

On April 25th at 11:50, Prof. Francois…

Read more  

Swiss Biotech Day 2024

MImAbs is attending the Swiss Biotech Day from April 22nd to 23rd in Basel.

Read more  

AACR 2024

MImAbs is attending AACR from 5th to 10th April 2024 in San Diego, California.

Read more  

14th World ADC 2024

MImAbs is attending the 14th World ADC from 12th to 15th March 2024 in London.

Read more  

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

Read the press release

Read more  

MImAbs Gets Certification from Alloy Therapeutics to Access ATX-GX™ Humanized Mice Platform for its Antibody Generation Services

MImAbs Gets Certification from Alloy Therapeutics to Access ATX-GX™ Humanized Mice Platform for its Antibody Generation…

Read more  

The pre-industrial demonstrator MImAbs creates a service company specializing in therapeutic antibodies

  • Carried by Aix-Marseille University (AMU), MImAbs is the first pre-industrial demonstrator of the Investments for…
Read more